These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 16373240)

  • 21. Enzyme immunoassay for occult faecal blood.
    Cervantes C; Vega H; Pérez L; Feliú R
    Z Med Lab Diagn; 1989; 30(8):431-6. PubMed ID: 2618135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Faecal pyruvate kinase type M2--a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study].
    Naumann M; Schaum B; Oremek GM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Dtsch Med Wochenschr; 2004 Aug; 129(34-35):1806-7. PubMed ID: 15314744
    [No Abstract]   [Full Text] [Related]  

  • 24. Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme.
    Itoh M; Takahashi K; Nishida H; Sakagami K; Okubo T
    J Med Screen; 1996; 3(2):66-71. PubMed ID: 8849762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
    Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening of colorectal cancer: indications and recommendations for a practical procedure].
    Porschen R
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):705-10. PubMed ID: 8237065
    [No Abstract]   [Full Text] [Related]  

  • 28. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
    Jansen JB; van Rossum LG; Laheij RJ
    Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric cancer after positive screening faecal occult blood testing and negative assessment.
    Zappa M; Visioli CB; Ciatto S; Grazzini G; Rubeca T; Bonanomi AG; Confortini M; Paci E; Castiglione G
    Dig Liver Dis; 2007 Apr; 39(4):321-6. PubMed ID: 17314076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for colorectal cancer.
    Brown ML
    N Engl J Med; 1993 Oct; 329(18):1352-3. PubMed ID: 8292163
    [No Abstract]   [Full Text] [Related]  

  • 32. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E; Brevinge H; Haglind E
    Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which colorectal cancer screening test is best?
    Mandel JS
    J Natl Cancer Inst; 2007 Oct; 99(19):1424-5. PubMed ID: 17895471
    [No Abstract]   [Full Text] [Related]  

  • 34. Automated immunochemical quantitation of haemoglobin in faeces collected on cards for screening for colorectal cancer.
    Fraser CG; Mathew CM; McKay K; Carey FA; Steele RJ
    Gut; 2008 Sep; 57(9):1256-60. PubMed ID: 18467371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is it time to recommend screening for colorectal cancer?
    Lieberman D; Sleisenger MH
    Lancet; 1996 Nov; 348(9040):1463-4. PubMed ID: 8942770
    [No Abstract]   [Full Text] [Related]  

  • 36. Importance of colorectal cancer screening.
    Hurst JS
    Am Fam Physician; 2003 Mar; 67(6):1188. PubMed ID: 12674445
    [No Abstract]   [Full Text] [Related]  

  • 37. Fecal-occult-blood test screening for colorectal cancer.
    Zacks M
    J Fam Pract; 1997 Mar; 44(3):247-8. PubMed ID: 9071239
    [No Abstract]   [Full Text] [Related]  

  • 38. Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate.
    Steele RJ; Gnauck R; Hrcka R; Kronborg O; Kuntz C; Moayyedi P; O'Morain C; Spicák J; Vainio H
    Endoscopy; 2004 Apr; 36(4):349-53. PubMed ID: 15057689
    [No Abstract]   [Full Text] [Related]  

  • 39. Screening for bowel cancer by faecal occult blood testing.
    Jackson CL
    Aust Fam Physician; 1994 Jun; 23(6):997, 999. PubMed ID: 8053858
    [No Abstract]   [Full Text] [Related]  

  • 40. The multidisciplinary management of gastrointestinal cancer. Colorectal cancer screening.
    Winawer SJ
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1031-48. PubMed ID: 18070702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.